Subscribe to Updates in Healthcare

RSS By Email

RSS By RSS

Add to Google Reader or Homepage

Subscribe in Bloglines


The Expertise Imperative and Compliance Technology
Access to a diverse array of specialized expert inputs drives superior decisions in every organizational context: within corporations, by investors and consultancies, and within nonprofits. When decision makers are confident of their decision inputs, they can respond more quickly and creatively to challenges and opportunities.Learn more about GLG's Compliance Framework


This page may include content provided by Council Members, your access to which is subject to the Terms of Use.
Find Out More

February 27, 2007

Xolair apprehension

This analysis is solely the work of the author. It has not been edited or endorsed by GLG.
Analysis By:
Mitchell Boxer, MD
Assistant Clinical Professor, Albert Einstein College of Medicine
Implications: There is a concern about anaphylaxis secondary to Xolair administration and this may result in longer waiting times after the administration of the drug.

Analysis: If there is a black box warning placed on Xolair, this would imply a 2 hour waiting time after drug administration. This would result in a significant fall off of patients receiving the drug secondary to this waiting period. I am not sure if the black box warning will actually take place as of yet and Genentech is planning a rebuttal to present to the FDA according to the recent meeting at the AAAAI in San Diego.

 


Other Analyses of the Same Source Article:
Xolair's anaphylaxis: Still helpful for severe asthma. Also give the patient an Epi Pen or Twinject
February 23, 2007, Author: David Engler, MD, Physician, The Allergy Clinic
Cause for Concern
February 23, 2007, Author: GLG Expert Contributor
Clearly NOT the panacea
February 23, 2007, Author: GLG Expert Contributor
Xolair's black mark
February 22, 2007, Author: GLG Expert Contributor

Report a Concern

GLG News: What Experts Think Is Important





Analytics


Generated at 2008-12-01T13:45:22.747